Patents by Inventor Helmut KERSCHBAUMER
Helmut KERSCHBAUMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12290604Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: August 15, 2022Date of Patent: May 6, 2025Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Patent number: 12290605Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: August 15, 2022Date of Patent: May 6, 2025Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Patent number: 12290606Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: August 15, 2022Date of Patent: May 6, 2025Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Patent number: 12290607Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: August 15, 2022Date of Patent: May 6, 2025Assignee: Laxxon Medical AG Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Patent number: 12285527Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: August 15, 2022Date of Patent: April 29, 2025Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Patent number: 12115130Abstract: A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.Type: GrantFiled: March 23, 2022Date of Patent: October 15, 2024Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Klaus Kühne, Helmut Kerschbaumer, Daniel Moldenhauer, Alexander Ruckdäschel, Achim Schneeberger
-
Patent number: 11986558Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.Type: GrantFiled: July 13, 2022Date of Patent: May 21, 2024Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Publication number: 20230078273Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: August 15, 2022Publication date: March 16, 2023Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20230008781Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: August 15, 2022Publication date: January 12, 2023Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20220387331Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: August 15, 2022Publication date: December 8, 2022Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20220387330Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: August 15, 2022Publication date: December 8, 2022Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20220387332Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: August 15, 2022Publication date: December 8, 2022Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Patent number: 11484504Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: GrantFiled: December 29, 2017Date of Patent: November 1, 2022Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Publication number: 20220339109Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.Type: ApplicationFiled: July 13, 2022Publication date: October 27, 2022Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20220304895Abstract: A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.Type: ApplicationFiled: March 23, 2022Publication date: September 29, 2022Inventors: Klaus KÜHNE, Helmut KERSCHBAUMER, Daniel MOLDENHAUER, Alexander RUCKDÄSCHEL, Achim SCHNEEBERGER
-
Patent number: 11419824Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.Type: GrantFiled: December 29, 2017Date of Patent: August 23, 2022Assignees: Laxxon Medical AG, Exentis Knowledge GmbHInventors: Achim Schneeberger, Klaus Kühne, Helmut Kerschbaumer, Srdan Vasic
-
Publication number: 20200390714Abstract: The present invention relates to a method for producing a drug delivery system. The method comprises the steps of screen-printing a base paste, and curing the base paste. Furthermore, the method comprises the steps of screen-printing a first paste separate to the base paste, and curing the first paste.Type: ApplicationFiled: December 29, 2017Publication date: December 17, 2020Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC
-
Publication number: 20200330390Abstract: The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.Type: ApplicationFiled: December 29, 2017Publication date: October 22, 2020Inventors: Achim SCHNEEBERGER, Klaus KÜHNE, Helmut KERSCHBAUMER, Srdan VASIC